Off-label Marketing
Off-Label Marketing is a regulatory and legal concept in pharmaceutical law denoting the promotion of a drug for uses, patient populations, or dosages not approved by the relevant regulatory authority, thereby distinguishing it from approved, labeling-compliant marketing practices.
22
Publications
816
Citations
42
Authors
30
Institutions
Publications per year
2017–2026
6
Parents
22
Off-Label Promotion, On-Target Sales
Adriane Fugh‐Berman, Douglas Melnick · PLoS Medicine · 2008 · 73 citations · Full text
1–5 of 22
42
4
h-index
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 42
30

Brigham and Women's Hospital
Boston, United States
4 h-index
9 publications
549 citations
University of Chicago
Chicago, United States
2 h-index
5 publications
137 citations
King's College London
London, United Kingdom
2 h-index
2 publications
63 citations

The University of Melbourne
Melbourne, Australia
2 h-index
2 publications
185 citations
Harvard University
Cambridge, United States
2 h-index
5 publications
443 citations

Lund University
Lund, Sweden
2 h-index
3 publications
107 citations
Larkin University
Miami, United States
1 h-index
1 publications
52 citations
University of Chicago Medical Center
Chicago, United States
1 h-index
2 publications
62 citations
1–8 of 30
4 publications · 302 citations
4
h-index
2 publications · 90 citations
2
h-index
JPP&M · 1 publications · 23 citations
1
h-index
1 publications · 51 citations
1
h-index
1 publications · 31 citations
1
h-index
1–5